Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms

被引:73
作者
Halvorsen, B [1 ]
Wæhre, T
Scholz, H
Clausen, OP
von der Thüsen, JH
Müller, F
Heimli, H
Tonstad, S
Hall, C
Froland, SS
Biessen, EA
Damås, JK
Aukrust, P
机构
[1] Natl Hosp Norway, Internal Med Res Inst, Oslo, Norway
[2] Natl Hosp Norway, Dept Cardiol, Oslo, Norway
[3] Natl Hosp Norway, Inst Pathol, Oslo, Norway
[4] Natl Hosp Norway, Inst Microbiol, Oslo, Norway
[5] Natl Hosp Norway, Sect Clin Immunol & Infect Dis, Oslo, Norway
[6] Univ Oslo, Ulleval Univ Hosp, Inst Nutr Res, N-0316 Oslo, Norway
[7] Univ Oslo, Ulleval Univ Hosp, Inst Prevent Cardiol, N-0316 Oslo, Norway
[8] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands
[9] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands
关键词
foam cell macrophages; acute coronary syndromes; atherosclerosis; apoptosis;
D O I
10.1194/jlr.M400324-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-10 may have a therapeutic potential in atherosclerosis, but its mechanisms of action have not been clarified. Foam cell formation is a key event in atherogenesis, and apoptosis of these lipid-laden cells may promote plaque destabilization. We sought to explore whether IL- 10 could have plaque-stabilizing properties in acute coronary syndromes (ACS). We studied the effect of IL-10 on oxidized low density lipoprotein (oxLDL)-stimulated THP-1 cells and monocyte-derived macrophages from ACS patients and healthy controls using different experimental approaches. Our main findings were: i) IL-10 enhances lipid accumulation in oxLDL-stimulated THP-1 macrophages, at least partly by counteracting oxLDI-induced apoptosis; ii) This antiapoptotic effect of IL-10 involves increased expression of the antiapoptotic genes Bfl-1 and Mcl-1, accompanied by protective effects on mitochondria function; iii) By silencing Bfl-1 and Mcl-1 genes using siRNAs, we were able to abolish this IL- 10-mediated effect on lipid accumulation; iv) IL-10 also induced hpid accumulation in oxLDL-stimulated macrophages from patients with ACS, but not in macrophages from healthy controls; v) In ACS patients, this enhancing effect of IL-10 on lipid accumulation was accompanied by enhanced Mcl-1 expression. No such antiapoptotic effect was seen in macrophages from healthy controls.jlr These findings suggest a new mechanism for the effect of IL-10 in atherosclerosis, possibly contributing to plaque stabilization.-Halvorsen, B., I Waehre, H. Scholz, O. P. Clausen,J. H. von der Thusen, E Muller, H. Heimli, S. Tonstad, C. Hall, S. S. Froland, E. A. Biessen,J. K. Damas, and P. Aukrust. Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 39 条
  • [1] Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina
    Anguera, I
    Miranda-Guardiola, F
    Bosch, X
    Filella, X
    Sitges, M
    Marín, J
    Betriu, A
    Sanz, G
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (05) : 811 - 817
  • [2] Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice
    Caligiuri, G
    Rudling, M
    Ollivier, V
    Jacob, MP
    Michel, JB
    Hansson, GK
    Nicoletti, A
    [J]. MOLECULAR MEDICINE, 2003, 9 (1-2) : 10 - 17
  • [3] Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2
    Cohen, SBA
    Crawley, JB
    Kahan, MC
    Feldmann, M
    Foxwell, BMJ
    [J]. IMMUNOLOGY, 1997, 92 (01) : 1 - 5
  • [4] Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation
    Daemen, MARC
    van't Veer, C
    Denecker, G
    Heemskerk, VH
    Wolfs, TGAM
    Clauss, M
    Vandenabeele, P
    Buurman, WA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (05) : 541 - 549
  • [5] Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
    Damås, JK
    Eiken, HG
    Oie, E
    Bjerkeli, V
    Yndestad, A
    Ueland, T
    Tonnessen, T
    Geiran, OR
    Aass, H
    Simonsen, S
    Christensen, G
    Froland, SS
    Attramadal, H
    Gullestad, L
    Aukrust, P
    [J]. CARDIOVASCULAR RESEARCH, 2000, 47 (04) : 778 - 787
  • [6] Cell death: Critical control points
    Danial, NN
    Korsmeyer, SJ
    [J]. CELL, 2004, 116 (02) : 205 - 219
  • [7] Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids
    Finstad, HS
    Myhrstad, MCW
    Heimli, H
    Lomo, J
    Blomhoff, HK
    Kolset, SO
    Drevon, CA
    [J]. LEUKEMIA, 1998, 12 (06) : 921 - 929
  • [8] Progression of atheroma - A struggle between death and procreation
    Geng, YH
    Libby, P
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (09) : 1370 - 1380
  • [9] USE OF MTT COLORIMETRIC ASSAY TO MEASURE CELL ACTIVATION
    GERLIER, D
    THOMASSET, N
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 94 (1-2) : 57 - 63
  • [10] Atherosclerosis: The road ahead
    Glass, CK
    Witztum, JL
    [J]. CELL, 2001, 104 (04) : 503 - 516